klow peptide capsules (GHK-CU, TB-500, BPC-157, KPV) KLOW Peptide KPV, BPC-157, TB-500

Voor een overzicht van onze Behandelingen klik hier

Product Overview BPC-157 / TB-500 combines two extensively studied peptide compounds within a single research preparation designed for controlled laboratory investigations involving peptide signalling systems, molecular communication pathways and peptide interaction models

(Explains that compounded medications under Section 503A are exempt from FDA pre-market approval requirements, meaning their safety and efficacy are not evaluated by FDA prior to use)

2009;60 Suppl 7:191196

Predictive model of severe atopic asthma phenotypes using interleukin 4/13 pathway polymorphisms